Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001077

Chief Accounting Officer sold 968 shares at $16.65 ($16,117)

  • Chief Accounting Officer acquired 968 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nolte Alexander Chief Accounting Officer 2022-01-31 Other acquisition +968 $12.39 $11,994 968 D: show line 1 in the form
Nolte Alexander Chief Accounting Officer 2022-02-01 Sale −968 $16.65 $16,117 0 D: show line 2 in the form
Open-market sales · 968 sh · avg $16.65 · $16,117

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nolte Alexander Chief Accounting Officer 2022-02-02 Grant or award · Stock Options (Right to buy) +30,000 $15.79 $473,700 30,000 D: show line 3 in the form
Loading xslF345X03/primarydocument.xml…